1. Home
  2. KEQU vs FENC Comparison

KEQU vs FENC Comparison

Compare KEQU & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$37.78

Market Cap

124.6M

Sector

Industrials

ML Signal

N/A

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

HOLD

Current Price

$7.62

Market Cap

258.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
FENC
Founded
1906
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
258.5M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
KEQU
FENC
Price
$37.78
$7.62
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
8.8K
196.5K
Earning Date
12-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
$38,790,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.22
P/E Ratio
$9.71
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$4.68
52 Week High
$71.33
$9.92

Technical Indicators

Market Signals
Indicator
KEQU
FENC
Relative Strength Index (RSI) 39.47 42.20
Support Level $37.50 $7.35
Resistance Level $41.04 $7.74
Average True Range (ATR) 1.44 0.36
MACD 0.21 -0.01
Stochastic Oscillator 19.69 20.00

Price Performance

Historical Comparison
KEQU
FENC

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: